Zhejiang Medicine Co Ltd (600216) — Cash Flow Quality Index
Zhejiang Medicine Co Ltd (600216) has a Cash Flow Quality Index of 2.66x as of September 2025. Operating cash flow of CN¥690.77 Million exceeds net income of CN¥259.84 Million, indicating high earnings quality where cash backs reported profits. Explore Zhejiang Medicine Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Medicine Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Zhejiang Medicine Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Medicine Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Zhejiang Medicine Co Ltd. For live market cap and the full company financial profile, see 600216 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.16x | CN¥1.89 Billion | CN¥873.38 Million | ▲ +80.1% |
| 2024 | 1.20x | CN¥1.22 Billion | CN¥1.02 Billion | ▼ -18.8% |
| 2023 | 1.48x | CN¥634.31 Million | CN¥429.64 Million | ▲ +2.8% |
| 2022 | 1.44x | CN¥520.60 Million | CN¥362.61 Million | ▲ +11.7% |
| 2021 | 1.29x | CN¥1.14 Billion | CN¥884.56 Million | ▼ -32.6% |
| 2020 | 1.91x | CN¥1.26 Billion | CN¥659.64 Million | ▲ +24.4% |
| 2019 | 1.53x | CN¥447.25 Million | CN¥291.95 Million | ▼ -13.6% |
| 2018 | 1.77x | CN¥579.91 Million | CN¥327.21 Million | ▼ -15.7% |
| 2017 | 2.10x | CN¥503.47 Million | CN¥239.54 Million | ▲ +177.8% |
| 2016 | 0.76x | CN¥336.14 Million | CN¥444.34 Million | ▲ +12.3% |
| 2015 | 0.67x | CN¥106.54 Million | CN¥158.22 Million | ▼ -79.0% |
| 2014 | 3.21x | CN¥549.90 Million | CN¥171.34 Million | ▲ +121.7% |
| 2013 | 1.45x | CN¥655.09 Million | CN¥452.60 Million | ▲ +52.6% |
| 2012 | 0.95x | CN¥807.49 Million | CN¥851.14 Million | ▲ +5.6% |
| 2011 | 0.90x | CN¥912.75 Million | CN¥1.02 Billion | ▼ -21.9% |
| 2010 | 1.15x | CN¥1.32 Billion | CN¥1.14 Billion | ▼ -4.7% |
| 2009 | 1.21x | CN¥1.47 Billion | CN¥1.21 Billion | ▼ -1.7% |
| 2008 | 1.23x | CN¥1.20 Billion | CN¥977.28 Million | ▼ -70.4% |
| 2007 | 4.14x | CN¥227.67 Million | CN¥54.95 Million | ▲ +44.9% |
| 2006 | 2.86x | CN¥169.51 Million | CN¥59.27 Million | ▲ +869.8% |
| 2005 | 0.29x | CN¥25.14 Million | CN¥85.27 Million | ▼ -96.9% |
| 2004 | 9.49x | CN¥107.60 Million | CN¥11.33 Million | ▼ -50.6% |
| 2003 | 19.20x | CN¥66.20 Million | CN¥3.45 Million | ▲ +1347.3% |
| 2002 | 1.33x | CN¥23.13 Million | CN¥17.43 Million | ▼ -79.5% |
| 2001 | 6.48x | CN¥98.25 Million | CN¥15.16 Million | ▲ +1178.3% |
| 2000 | 0.51x | CN¥10.58 Million | CN¥20.87 Million | ▲ +138.4% |
| 1999 | -1.32x | CN¥-51.90 Million | CN¥39.29 Million | ▼ -189.9% |
| 1998 | 1.47x | CN¥57.72 Million | CN¥39.27 Million | — |